ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Arthritis Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-21V8708
Home | Market Reports | Health| Pharmacy| Drugs & Medications
China Arthritis Drug Market Report Forecast 2021 2027
BUY CHAPTERS

Global Arthritis Drug Market Research Report 2025

Code: QYRE-Auto-21V8708
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Eli Lilly
Celltrion
F.Hoffmann-La Roche
Pfizer Inc
Johnson & Johnson
GSK

Arthritis Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Arthritis Drug Market

Arthritis Drug Market

The global market for Arthritis Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Arthritis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Drug.
The Arthritis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Arthritis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arthritis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Arthritis Drug Market Report

Report Metric Details
Report Name Arthritis Drug Market
CAGR 5%
Segment by Type
  • Synthetic DMARDs
  • Biological DMARDs
  • NSAIDs
  • Corticosteroids
  • Analgesics
Segment by Application
  • Retail Pharmacies
  • Hospital Pharmacies
  • Drug Stores
  • E-Commerce
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Eli Lilly, Celltrion, F. Hoffmann-La Roche, Pfizer, Johnson & Johnson, GSK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Arthritis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Arthritis Drug Market report?

Ans: The main players in the Arthritis Drug Market are Novartis, Eli Lilly, Celltrion, F. Hoffmann-La Roche, Pfizer, Johnson & Johnson, GSK

What are the Application segmentation covered in the Arthritis Drug Market report?

Ans: The Applications covered in the Arthritis Drug Market report are Retail Pharmacies, Hospital Pharmacies, Drug Stores, E-Commerce

What are the Type segmentation covered in the Arthritis Drug Market report?

Ans: The Types covered in the Arthritis Drug Market report are Synthetic DMARDs, Biological DMARDs, NSAIDs, Corticosteroids, Analgesics

1 Arthritis Drug Market Overview
1.1 Product Definition
1.2 Arthritis Drug by Type
1.2.1 Global Arthritis Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Synthetic DMARDs
1.2.3 Biological DMARDs
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.2.6 Analgesics
1.3 Arthritis Drug by Application
1.3.1 Global Arthritis Drug Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Arthritis Drug Market Size Estimates and Forecasts
1.4.1 Global Arthritis Drug Revenue 2020-2031
1.4.2 Global Arthritis Drug Sales 2020-2031
1.4.3 Global Arthritis Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Arthritis Drug Market Competition by Manufacturers
2.1 Global Arthritis Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Arthritis Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Arthritis Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Arthritis Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Arthritis Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Arthritis Drug, Product Type & Application
2.7 Global Key Manufacturers of Arthritis Drug, Date of Enter into This Industry
2.8 Global Arthritis Drug Market Competitive Situation and Trends
2.8.1 Global Arthritis Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Arthritis Drug Players Market Share by Revenue
2.8.3 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Arthritis Drug Market Scenario by Region
3.1 Global Arthritis Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Arthritis Drug Sales by Region: 2020-2031
3.2.1 Global Arthritis Drug Sales by Region: 2020-2025
3.2.2 Global Arthritis Drug Sales by Region: 2026-2031
3.3 Global Arthritis Drug Revenue by Region: 2020-2031
3.3.1 Global Arthritis Drug Revenue by Region: 2020-2025
3.3.2 Global Arthritis Drug Revenue by Region: 2026-2031
3.4 North America Arthritis Drug Market Facts & Figures by Country
3.4.1 North America Arthritis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Arthritis Drug Sales by Country (2020-2031)
3.4.3 North America Arthritis Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Arthritis Drug Market Facts & Figures by Country
3.5.1 Europe Arthritis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Arthritis Drug Sales by Country (2020-2031)
3.5.3 Europe Arthritis Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Arthritis Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Arthritis Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Arthritis Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Arthritis Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Arthritis Drug Market Facts & Figures by Country
3.7.1 Latin America Arthritis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Arthritis Drug Sales by Country (2020-2031)
3.7.3 Latin America Arthritis Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Arthritis Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Arthritis Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Arthritis Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Arthritis Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Arthritis Drug Sales by Type (2020-2031)
4.1.1 Global Arthritis Drug Sales by Type (2020-2025)
4.1.2 Global Arthritis Drug Sales by Type (2026-2031)
4.1.3 Global Arthritis Drug Sales Market Share by Type (2020-2031)
4.2 Global Arthritis Drug Revenue by Type (2020-2031)
4.2.1 Global Arthritis Drug Revenue by Type (2020-2025)
4.2.2 Global Arthritis Drug Revenue by Type (2026-2031)
4.2.3 Global Arthritis Drug Revenue Market Share by Type (2020-2031)
4.3 Global Arthritis Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Arthritis Drug Sales by Application (2020-2031)
5.1.1 Global Arthritis Drug Sales by Application (2020-2025)
5.1.2 Global Arthritis Drug Sales by Application (2026-2031)
5.1.3 Global Arthritis Drug Sales Market Share by Application (2020-2031)
5.2 Global Arthritis Drug Revenue by Application (2020-2031)
5.2.1 Global Arthritis Drug Revenue by Application (2020-2025)
5.2.2 Global Arthritis Drug Revenue by Application (2026-2031)
5.2.3 Global Arthritis Drug Revenue Market Share by Application (2020-2031)
5.3 Global Arthritis Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Arthritis Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Arthritis Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Celltrion
6.3.1 Celltrion Company Information
6.3.2 Celltrion Description and Business Overview
6.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Celltrion Arthritis Drug Product Portfolio
6.3.5 Celltrion Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Company Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Arthritis Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Arthritis Drug Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GSK
6.7.1 GSK Company Information
6.7.2 GSK Description and Business Overview
6.7.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSK Arthritis Drug Product Portfolio
6.7.5 GSK Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Arthritis Drug Industry Chain Analysis
7.2 Arthritis Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Arthritis Drug Production Mode & Process Analysis
7.4 Arthritis Drug Sales and Marketing
7.4.1 Arthritis Drug Sales Channels
7.4.2 Arthritis Drug Distributors
7.5 Arthritis Drug Customer Analysis
8 Arthritis Drug Market Dynamics
8.1 Arthritis Drug Industry Trends
8.2 Arthritis Drug Market Drivers
8.3 Arthritis Drug Market Challenges
8.4 Arthritis Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Eli Lilly
Celltrion
F.Hoffmann-La Roche
Pfizer Inc
Johnson & Johnson
GSK
List of Tables
 Table 1. Global Arthritis Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Arthritis Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Arthritis Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Arthritis Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Arthritis Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Arthritis Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Arthritis Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Arthritis Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Arthritis Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Arthritis Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Arthritis Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Arthritis Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Arthritis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Arthritis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Arthritis Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Arthritis Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Arthritis Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Arthritis Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Arthritis Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Arthritis Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Arthritis Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Arthritis Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Arthritis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Arthritis Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Arthritis Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Arthritis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Arthritis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Arthritis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Arthritis Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Arthritis Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Arthritis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Arthritis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Arthritis Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Arthritis Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Arthritis Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Arthritis Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Arthritis Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Arthritis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Arthritis Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Arthritis Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Arthritis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Arthritis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Arthritis Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Arthritis Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Arthritis Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Arthritis Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Arthritis Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Arthritis Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Arthritis Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Arthritis Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Arthritis Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Arthritis Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Arthritis Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Arthritis Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Arthritis Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Arthritis Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Arthritis Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Arthritis Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Arthritis Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Arthritis Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Arthritis Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Arthritis Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Arthritis Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Arthritis Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Arthritis Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Arthritis Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Arthritis Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Arthritis Drug Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly Arthritis Drug Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Celltrion Company Information
 Table 81. Celltrion Description and Business Overview
 Table 82. Celltrion Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Celltrion Arthritis Drug Product
 Table 84. Celltrion Recent Developments/Updates
 Table 85. F. Hoffmann-La Roche Company Information
 Table 86. F. Hoffmann-La Roche Description and Business Overview
 Table 87. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. F. Hoffmann-La Roche Arthritis Drug Product
 Table 89. F. Hoffmann-La Roche Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Arthritis Drug Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Arthritis Drug Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. GSK Company Information
 Table 101. GSK Description and Business Overview
 Table 102. GSK Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. GSK Arthritis Drug Product
 Table 104. GSK Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Arthritis Drug Distributors List
 Table 108. Arthritis Drug Customers List
 Table 109. Arthritis Drug Market Trends
 Table 110. Arthritis Drug Market Drivers
 Table 111. Arthritis Drug Market Challenges
 Table 112. Arthritis Drug Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Arthritis Drug
 Figure 2. Global Arthritis Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Arthritis Drug Market Share by Type: 2024 & 2031
 Figure 4. Synthetic DMARDs Product Picture
 Figure 5. Biological DMARDs Product Picture
 Figure 6. NSAIDs Product Picture
 Figure 7. Corticosteroids Product Picture
 Figure 8. Analgesics Product Picture
 Figure 9. Global Arthritis Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Arthritis Drug Market Share by Application: 2024 & 2031
 Figure 11. Retail Pharmacies
 Figure 12. Hospital Pharmacies
 Figure 13. Drug Stores
 Figure 14. E-Commerce
 Figure 15. Global Arthritis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Arthritis Drug Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Arthritis Drug Sales (2020-2031) & (K Units)
 Figure 18. Global Arthritis Drug Average Price (USD/Unit) & (2020-2031)
 Figure 19. Arthritis Drug Report Years Considered
 Figure 20. Arthritis Drug Sales Share by Manufacturers in 2024
 Figure 21. Global Arthritis Drug Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Arthritis Drug Players: Market Share by Revenue in Arthritis Drug in 2024
 Figure 23. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Arthritis Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Arthritis Drug Sales Market Share by Country (2020-2031)
 Figure 26. North America Arthritis Drug Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Arthritis Drug Sales Market Share by Country (2020-2031)
 Figure 30. Europe Arthritis Drug Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Arthritis Drug Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Arthritis Drug Revenue Market Share by Region (2020-2031)
 Figure 38. China Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Arthritis Drug Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Arthritis Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Arthritis Drug Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Arthritis Drug Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Arthritis Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Arthritis Drug by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Arthritis Drug by Type (2020-2031)
 Figure 60. Global Arthritis Drug Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Arthritis Drug by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Arthritis Drug by Application (2020-2031)
 Figure 63. Global Arthritis Drug Price (USD/Unit) by Application (2020-2031)
 Figure 64. Arthritis Drug Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions